BioAge Labs, Inc.
BIOA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709941
No open-market purchases or sales by BioAge Labs, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding BioAge Labs, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 83 | 94 | +11 |
| Shares | 20.7M | 21.3M | +542.6K (+2.6%) |
| Value | $85.6M | $125.0M | +$39.4M (+46.1%) |
New holders (14)
Institutions that held BioAge Labs, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Los Angeles Capital Management LLC | 120,929 | $711.1K | 0.00% |
| Gsa Capital Partners LLP | 30,723 | $181.0K | 0.02% |
| R Squared Ltd | 26,159 | $153.8K | 0.07% |
| Occudo Quantitative Strategies LP | 19,295 | $113.5K | 0.01% |
| Price T Rowe Associates Inc | 11,891 | $70.0K | 0.00% |
| Quadrature Capital Ltd | 10,734 | $63.1K | 0.00% |
| Russell Investments Group, Ltd. | 4,529 | $26.6K | 0.00% |
| SRS Capital Advisors, Inc. | 474 | $2.79K | 0.00% |
| Cornerstone Planning Group LLC | 100 | $725 | 0.00% |
| Fortitude Family Office, LLC | 120 | $706 | 0.00% |
| Farther Finance Advisors, LLC | 101 | $594 | 0.00% |
| Principal Securities, Inc. | 41 | $241 | 0.00% |
| Advisory Services Network, LLC | 13 | $76 | 0.00% |
| IFP Advisors, Inc | 2 | $12 | 0.00% |
Sold out (3)
Institutions that held BioAge Labs, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Cantor Fitzgerald, L. P. | 200,000 | $826.0K |
| Jefferies Financial Group Inc. | 50,000 | $206.5K |
| Virtu Financial LLC | 14,911 | $62.0K |